Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics
05/11/2025 14:04
Nov 5 (Reuters) - Co-Diagnostics Inc CODX.O: CO-DIAGNOSTICS ENGAGES MAXIM GROUP TO PURSUE SPAC TRANSACTION FOR ITS INDIAN JOINT VENTURE, COSARA DIAGNOSTICS PVT. LTD Source text: ID:nPn60cpSWa Further company coverage: CODX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Co-Diagnostics
See all newsDiagnostics' Joint Venture Cosara Diagnostics Announces Publication Of Peer-Reviewed Hpv Screening Study Using Cosara's Saragene® Test
Diagnostics - Cosara To Initiate Sales Activities Across India And South Asia
Diagnostics’ Brian Brown Stepped Down As CFO Effective September 2
Diagnostics Q2 revenue rises slightly amid international expansion
Diagnostics - Amends Equity Distribution Agreement With Maxim Group For Common Stock Sale - SEC Filing